Search results
Results from the WOW.Com Content Network
Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur , Mortimer , and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.
The Sackler family is an American family who owned the pharmaceutical company Purdue Pharma and later founded Mundipharma. [1] Purdue Pharma, and some members of the family, have faced lawsuits regarding overprescription of addictive pharmaceutical drugs, including OxyContin.
The end of the Purdue Pharma bankruptcy case has left a bitter taste for those who wanted to see more accountability for members of the Sackler family. The Sacklers will give up ownership of the ...
Sackler joined Purdue Pharma in 1971, as assistant to his father, the company's president. [10] He became head of research and development and head of marketing. Sackler was a key figure in the development of Oxycontin, being the moving force behind Purdue Pharma's research around 1990 that pushed Oxycontin to replace MS Contin that was about to have generic competition.
But the Purdue Pharma settlement would have been only the second so far to include direct payments to victims from a $750 million pool. Payouts would have ranged from about $3,500 to $48,000.
Purdue flourished under brothers Mortimer and Raymond Sackler, who died in 2010 and 2017, respectively. The family reaped billions and spent lavishly, including on splashy charitable projects .
Massachusetts v. Purdue is a lawsuit filed on August 14, 2018, suing the Stamford, Connecticut-based company Purdue Pharma LP, which created and manufactures OxyContin, "one of the most widely used and prescribed opioid drugs on the market", and Purdue's owners, the Sacklers [1] accusing them of "widespread fraud and deception in the marketing of opioids, and contributing to the opioid crisis ...
Purdue Pharma's creditors sought permission from a U.S. bankruptcy court on Monday to sue the company's wealthy owners, arguing that the litigation can serve as both a negotiating tool and a ...